Table 2.
Clinical information for the patients and controls
| Parameters | MCD | MN | FSGS | TIN | Donor | Normal adjacent tissues |
|---|---|---|---|---|---|---|
| Number | 9 | 9 | 4 | 3 | 3 | 3 |
| Male/female | 5/4 | 5/4 | 2/2 | 2/1 | 1/2 | 2/1 |
| Age [years] | 37.0 ± 15.4 | 57.8 ± 9.78 | 48.5 ± 27.1 | 54.0 ± 15.8 | 38.3 ± 14.6 | 65.7 ± 4.5 |
| Duration of disease [months] | 13.3 ± 17.1 | 13.6 ± 15.6 | 22.5 ± 41.0 | 1.8 ± 1.3 | - | 5.7 ± 5.5 |
| Duration of the current relapse [months] | 7.7 ± 15.6 | 8.3 ± 15.2 | 21.6 ± 41.6 | - | - | - |
| Urinary protein [g/d] | 8.76 ± 4.37 | 8.12 ± 4.05 | 6.89 ± 4.58 | 1.38 ± 0.32 | - | - |
| Serum Albumin [g/L] | 21.4 ± 4.1 | 28.0 ± 5.4 | 28.9 ± 13.8 | 40.9 ± 6.3 | 41.7 ± 2.1 | 40 ± 1.8 |
| Serum Creatinine [μmol/L] | 105.4 ± 74.7 | 82.6 ± 29.6 | 165.1 ± 181.7 | 207.4 ± 147.5 | 72.4 ± 14.5 | 91.3 ± 17.2 |
| Glucocorticoids treated/untreated before this relapse | 2/7 | 1/8 | 1/4 | 0/4 | - | - |
| Glucocorticoids treated/untreated for this relapse | 0/9 | 0/9 | 0/4 | 0/3 | - | - |
Values are means ± standard deviation; FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous nephropathy; TIN, tubulointerstitial nephritis.